Protection against Acetaminophen Toxicity in CYP1A2 and CYP2E1 Double-Null Mice
- 1 September 1998
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 152 (1) , 193-199
- https://doi.org/10.1006/taap.1998.8501
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Selective Protein Arylation and Acetaminophen-Induced HepatotoxicityDrug Metabolism Reviews, 1997
- Immunohistochemical Localization of Acetaminophen in Target Tissues of the CD-1 Mouse: Correspondence of Covalent Binding with ToxicityFundamental and Applied Toxicology, 1995
- Acetaminophen Nephrotoxicity in CD-1 Mice: I. Evidence of a Role for in Situ Activation in Selective Covalent Binding and ToxicityToxicology and Applied Pharmacology, 1994
- Purification, antibody production, and partial amino acid sequence of the 58-kDa acetaminophen-binding liver proteinsToxicology and Applied Pharmacology, 1992
- Immunochemical analysis of acetaminophen covalent binding to proteinsBiochemical Pharmacology, 1988
- Immunochemical detection of acetaminophen-bound liver proteinsBiochemical Pharmacology, 1987
- Age-related changes in renal metabolism of acetaminophen in male Fischer 344 ratsAGE, 1986
- Acetaminophen HepatotoxicityAnnual Review of Medicine, 1984
- Reactive metabolites of phenacetin and acetaminophen: a reviewEnvironmental Health Perspectives, 1983
- Tissue sulfhydryl groupsArchives of Biochemistry and Biophysics, 1959